FindTrial
Sign In

urine I-FABP combined with C5a in early diagnosis of neonatal necrotizing enterocolitis

urine I-FABP combined with C5a in early diagnosis of neonatal necrotizing enterocolitis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-17013716
Enrollment
Unknown
Registered
2017-12-05
Start date
2017-12-01
Completion date
Unknown
Last updated
2017-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal necrotizing enterocolitis

Interventions

Gold Standard:Abdominal X-ray plain film
Index test:I-FABP and C5a

Sponsors

Children's Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients were identified if they were classified in the database as having proven NEC; Control patients were those admitted to the same institution for medical reasons other than NEC.

Exclusion criteria

Exclusion criteria: The hospitalization time was less than 24 h, shock, septicaemia, systemic inflammatory response syndrome, alimentary canal deformity, and genetic metabolic diseases

Design outcomes

Primary

MeasureTime frame
I-FABP;C5a;SPE, SEN, ACC;—

Countries

China

Contacts

Public ContactQi Lu

Children's Hospital of Chongqing Medical University

qilu_qi@163.com+86 15823020185

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026